Jamie David Conklin, MD | |
2500 Ne Neff Rd, Bend, OR 97701-6015 | |
(541) 706-7715 | |
(541) 598-3492 |
Full Name | Jamie David Conklin |
---|---|
Gender | Male |
Speciality | Critical Care (intensivists) |
Experience | 19 Years |
Location | 2500 Ne Neff Rd, Bend, Oregon |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467640961 | NPI | - | NPPES |
500641194 | Medicaid | OR |
Facility Name | Location | Facility Type |
---|---|---|
Sacred Heart Medical Center - Riverbend | Springfield, OR | Hospital |
Mckenzie-willamette Medical Center | Springfield, OR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Sound Physicians Intensivists Of Washington Pllc | 5395018808 | 71 |
Peacehealth | 8527016039 | 174 |
Sound Physicians Intensivists Of Washington Pllc | 5395018808 | 71 |
News Archive
Robbins Geller Rudman & Dowd LLP ("Robbins Geller") today announced that an amended class action complaint will be filed in the United States District Court for the Southern District of New York. The amended complaint will be on behalf of purchasers of Pfizer Inc. publicly traded securities during the period between January 19, 2006 and January 23, 2009.
Scientists have discovered a T-cell receptor that has proven effective in targeting a variety of cancers in mice and in human cells within the lab.
A research group led by Professor Yasuko Mori (Division of Clinical Virology, Center for Infectious Diseases, Kobe University) have succeeded in humanization of mouse antibodies that can neutralize the infection caused by human herpesvirus 6B.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is presenting results of a study demonstrating the effectiveness of Valortim® in an inhalation anthrax model in the New Zealand White (NZW) rabbit.
Hepatitis B and hepatitis C are viral infections, which are mostly transmitted by blood. Often unnoticed, they can become chronic, causing irreversible damage to the liver.
› Verified 3 days ago
Entity Name | Peacehealth |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740223874 PECOS PAC ID: 8527016039 Enrollment ID: O20050111000353 |
News Archive
Robbins Geller Rudman & Dowd LLP ("Robbins Geller") today announced that an amended class action complaint will be filed in the United States District Court for the Southern District of New York. The amended complaint will be on behalf of purchasers of Pfizer Inc. publicly traded securities during the period between January 19, 2006 and January 23, 2009.
Scientists have discovered a T-cell receptor that has proven effective in targeting a variety of cancers in mice and in human cells within the lab.
A research group led by Professor Yasuko Mori (Division of Clinical Virology, Center for Infectious Diseases, Kobe University) have succeeded in humanization of mouse antibodies that can neutralize the infection caused by human herpesvirus 6B.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is presenting results of a study demonstrating the effectiveness of Valortim® in an inhalation anthrax model in the New Zealand White (NZW) rabbit.
Hepatitis B and hepatitis C are viral infections, which are mostly transmitted by blood. Often unnoticed, they can become chronic, causing irreversible damage to the liver.
› Verified 3 days ago
Entity Name | Sound Physicians Intensivists Of Washington Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528582699 PECOS PAC ID: 5395018808 Enrollment ID: O20211101000140 |
News Archive
Robbins Geller Rudman & Dowd LLP ("Robbins Geller") today announced that an amended class action complaint will be filed in the United States District Court for the Southern District of New York. The amended complaint will be on behalf of purchasers of Pfizer Inc. publicly traded securities during the period between January 19, 2006 and January 23, 2009.
Scientists have discovered a T-cell receptor that has proven effective in targeting a variety of cancers in mice and in human cells within the lab.
A research group led by Professor Yasuko Mori (Division of Clinical Virology, Center for Infectious Diseases, Kobe University) have succeeded in humanization of mouse antibodies that can neutralize the infection caused by human herpesvirus 6B.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is presenting results of a study demonstrating the effectiveness of Valortim® in an inhalation anthrax model in the New Zealand White (NZW) rabbit.
Hepatitis B and hepatitis C are viral infections, which are mostly transmitted by blood. Often unnoticed, they can become chronic, causing irreversible damage to the liver.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Jamie David Conklin, MD Po Box 5579, Bend, OR 97708-5579 Ph: (541) 706-7715 | Jamie David Conklin, MD 2500 Ne Neff Rd, Bend, OR 97701-6015 Ph: (541) 706-7715 |
News Archive
Robbins Geller Rudman & Dowd LLP ("Robbins Geller") today announced that an amended class action complaint will be filed in the United States District Court for the Southern District of New York. The amended complaint will be on behalf of purchasers of Pfizer Inc. publicly traded securities during the period between January 19, 2006 and January 23, 2009.
Scientists have discovered a T-cell receptor that has proven effective in targeting a variety of cancers in mice and in human cells within the lab.
A research group led by Professor Yasuko Mori (Division of Clinical Virology, Center for Infectious Diseases, Kobe University) have succeeded in humanization of mouse antibodies that can neutralize the infection caused by human herpesvirus 6B.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is presenting results of a study demonstrating the effectiveness of Valortim® in an inhalation anthrax model in the New Zealand White (NZW) rabbit.
Hepatitis B and hepatitis C are viral infections, which are mostly transmitted by blood. Often unnoticed, they can become chronic, causing irreversible damage to the liver.
› Verified 3 days ago
Alanna Mozena, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-706-6892 Fax: 541-706-6813 | |
Ashley Marie Twyman, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-706-6892 Fax: 541-706-6813 | |
Dr. Gilbert B. Lee, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1558 Sw Nancy Way, Bend, OR 97702 Phone: 541-312-8679 | |
Ms. Christine Marie Pierson, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2965 Ne Conners Ave, Ste 280, Bend, OR 97701 Phone: 541-323-4269 | |
Dr. Michael N Harris, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1501 Ne Medical Center Dr, Bend, OR 97701 Phone: 541-382-2811 | |
Gordon Jeremy Juriansz, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-706-6892 | |
Dr. Ronald Daniel Rosen, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 918 Ne 5th St, Bend, OR 97701 Phone: 541-388-3804 Fax: 541-388-3856 |